New pill shows promise in shrinking belly fat without diabetes
NCT ID NCT06824051
First seen Jan 22, 2026 · Last updated Apr 29, 2026 · Updated 19 times
Summary
This study tested a new drug called orforglipron to see how it affects body fat in 120 adults with obesity or overweight who do not have diabetes. Participants took either the drug or a placebo for about 8 months. The main goal was to measure changes in belly fat and overall body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Axis
Dilworth, Minnesota, 56529, United States
-
Clinical Pharmacology of Miami
Miami, Florida, 33172, United States
-
Endeavor Clinical Trials
San Antonio, Texas, 78240, United States
-
Ohio Clinical Trials
Columbus, Ohio, 43212, United States
Conditions
Explore the condition pages connected to this study.